Should retest the highs of early March with clinical trials in US announced with China and South Korea to follow. Expect negative stories of lawsuits and historical track record to persist otherwise I agree with many that INO with VGX-3100 could have a market cap similar in range to Moderna MRNA 11B+. That would make INO share price 9x in the 72-80 range.
تم فتح الصفقة:
No resistance above. Small float. Rally should continue.